Extra-renal non-cerebral malignant rhabdoid tumor in children: does maintenance chemotherapy play a role in survival?
Diagnosis and Management of Multiple Myeloma: A Review.
Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, Tuazon S, Gopal AK, Libby EN.
JAMA. 2022 Feb 1;327(5):464-477. doi: 10.1001/jama.2022.0003.
Chemotherapy Maintenance.
Kasi PM, Grothey A.
Cancer J. 2016 May-Jun;22(3):199-204. doi: 10.1097/PPO.0000000000000195.
The Role of Maintenance Strategies in Metastatic Colorectal Cancer: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials.
Sonbol MB, Mountjoy LJ, Firwana B, Liu AJ, Almader-Douglas D, Mody K, Hubbard J, Borad M, Ahn DH, Murad MH, Bekaii-Saab T.
JAMA Oncol. 2020 Mar 1;6(3):e194489. doi: 10.1001/jamaoncol.2019.4489. Epub 2020 Mar 12.
Maintenance Therapy in Acute Myeloid Leukemia.
Sabakhtarishvili G, Ansari A, Tabbara IA.
Am J Clin Oncol. 2025 Jan 1;48(1):38-43. doi: 10.1097/COC.0000000000001140. Epub 2024 Sep 6.
Progression-free survival and safety at 3.5years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer.
González-Martín A, Pothuri B, Vergote I, Graybill W, Lorusso D, McCormick CC, Freyer G, Backes F, Heitz F, Redondo A, Moore RG, Vulsteke C, O'Cearbhaill RE, Malinowska IA, Shtessel L, Compton N, Mirza MR, Monk BJ.
Eur J Cancer. 2023 Aug;189:112908. doi: 10.1016/j.ejca.2023.04.024. Epub 2023 May 3.
Treatment and biology of pediatric acute lymphoblastic leukemia.
Kato M, Manabe A.
Pediatr Int. 2018 Jan;60(1):4-12. doi: 10.1111/ped.13457.
Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial.
Bisogno G, De Salvo GL, Bergeron C, Gallego Melcón S, Merks JH, Kelsey A, Martelli H, Minard-Colin V, Orbach D, Glosli H, Chisholm J, Casanova M, Zanetti I, Devalck C, Ben-Arush M, Mudry P, Ferman S, Jenney M, Ferrari A; European paediatric Soft tissue sarcoma Study Group.
Lancet Oncol. 2019 Nov;20(11):1566-1575. doi: 10.1016/S1470-2045(19)30617-5. Epub 2019 Sep 24.
How I use maintenance therapy in acute myeloid leukemia.
Roboz GJ, Canaani J.
Blood. 2025 Mar 20;145(12):1273-1281. doi: 10.1182/blood.2024024010.
Blinatumomab as postremission therapy replaces consolidation and substantial parts of maintenance chemotherapy and results in stable MRD negativity in children with newly diagnosed B-lineage ALL.
Mikhailova E, Popov A, Roumiantseva J, Budanov O, Lagoyko S, Zharikova L, Miakova N, Litvinov D, Khachatryan L, Pshonkin A, Ponomareva N, Boichenko E, Varfolomeeva S, Dinikina J, Novichkova G, Henze G, Karachunskiy A.
J Immunother Cancer. 2024 Jun 6;12(6):e008213. doi: 10.1136/jitc-2023-008213.
Systematic Review on the Utilization of Maintenance Intravesical Chemotherapy in the Management of Non-muscle-invasive Bladder Cancer.
Tabayoyong WB, Kamat AM, O'Donnell MA, McKiernan JM, Ray-Zack MD, Palou J, Brausi M, Black PC, Williams SB.
Eur Urol Focus. 2018 Jul;4(4):512-521. doi: 10.1016/j.euf.2018.08.019. Epub 2018 Sep 3.
